Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move
(TSXV: $ZENA.V) (CSE: $HITI.C) (OTCQB: $HITIF)(TSXV: $KHRN.V) (OTCQB: $KHRNF)
Delta, Kelowna, BC –April
29th, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its potcast
site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/04291ZENA-HITI-HITIF-KHRN-KHRNF.asp
Today’s podcast overview/transcript:
Good
morning and welcome to another episode of Investorideas.com “potcasts”, looking
at cannabis news, stocks to watch as well as insights from thought leaders and
experts.
Today’s
podcast begins with an introduction of myself, Taylor Van Zant the host of our
“potcasts” and after that I focus on a few early announcements from a few
interesting companies.
Khiron Life
Sciences Corp. (TSXV: KHRN), (OTCQB: KHRNF), an integrated cannabis company with its
core operations in Latin America, announced today that the Company has signed an LOI with
Copservir Ltda., Colombia's largest pharmacy chain, to distribute Khiron's
medical cannabis products across the country. The companies have agreed to
initial discounting and commercial fees and will work towards establishing a
definitive commercial contract and detailed distribution plan to begin sales in
the second half of 2019.
As
Colombia's largest pharmacy chain, Copservir Ltda., operates over 900 stores
across 200 cities and municipalities with a traditional brick and mortar
presence representing 75% of its CAD 500 Million / year sales. In addition, a
growing virtual presence represents 25% of its sales with an annual growth rate
of over 20%. The company combines its retail and virtual presence with a strong
distribution and logistics platform with four distribution centres in the main
cities of Colombia and a home delivery service in 120 cities. This makes the
Colombian Government-administered company the largest by store-count pharmacy
chain in the country.
On
completion of the agreement, Khiron will have established a compliant and
secure distribution platform for its medical products across Colombia, starting
with its custom-made pharmacy compound strategy. Copservir's extensive
brick-and-mortar presence, virtual channel and distribution capability will
allow Khiron to offer patients across the country the option for pick-up or
home delivery of their medical cannabis formulations. Coupled with Khiron's
ongoing medical education platform to educate and engage doctors and physicians
across the country, this distribution strategy will allow Khiron to reach more
patients in a safe, compliant and innovative matter.
Alvaro
Torres, Khiron CEO and Director commented, "The proposed agreement with
Copservir Ltda. represents a significant development for Khiron, offering the
opportunity to leverage our first mover advantage to distribute medical
cannabis products across Colombia and service the more than 5 million potential
patients in the country. We also view Copservir entering the medical cannabis
market as a milestone validation of the market opportunity in Colombia. By
offering a platform that makes it easier for patients to access their
formulations in a compliant and safe manner, Khiron establishes a leadership
position in the medical cannabis market in Colombia."
The
companies will work towards establishing definite commercial and distribution
agreements to begin sales in the second half of 2019.
High
Tide Inc. (CSE:HITI) (OTCQB:HITIF), an Alberta-based, retail-focused
cannabis corporation enhanced by the manufacturing and wholesale distribution
of smoking accessories and cannabis lifestyle products, announced that on Friday, April 26, 2019 the Alcohol
and Gaming Commission of Ontario ("AGCO") approved and issued a
Retail Operator Licence to High Tide's counterparty Dana Michele Kendal for the
Canna Cabana Toronto store. A Retail
Store Authorization will also be required to be issued by the AGCO for the
Winner to finalize the set-up of the Toronto Store. The Winner is aiming to
open Canna Cabana Toronto on or before June 1, 2019.
The Toronto Store is expected to be highest
profile Canna Cabana-branded location in Canada. "From originally being
selected by the Winner to help establish the Toronto Store, to achieving this
important milestone part-way through the process, we are growing very keen to
open this shop near the intersection of Yonge Street and College Street,"
said Raj Grover, President and Chief Executive Officer of High Tide. "High
Tide's best efforts are being put toward this project and we look forward to
the privilege of the Toronto Store becoming a part of the surrounding community
for the long term," added Mr. Grover.
Prior to opening the Toronto Store, the AGCO will conduct a pre-opening
inspection to ensure that the Winner is ready to sell cannabis products to the
public in accordance with the regulations and standards for cannabis retail
stores.
Zenabis Global Inc.
(TSXV:
ZENA) (OTC:ZBISF) announced that it has entered into a binding term
sheet for a three-year supply arrangement with leading German pharmaceutical
research company Farmako GmbH for: (1) the supply of biosynthetically produced
pure CBD isolate oil (99.9%) from Farmako to Zenabis for sale in Canada; and
(2) the supply of European Union Good Manufacturing Practices certified
cannabis cultivated in Zenabis' indoor facilities in Canada for sale by Farmako
to the German medical market.
Andrew
Grieve, Chief Executive Officer of Zenabis, stated, "While Zenabis is committed to producing both hemp- and
cannabis-derived CBD products, we are thrilled to have signed the very first
commercial agreement globally of its kind for the purchase of biosynthetic
cannabinoids. We are purchasing the CBD
isolates from Farmako at an incredibly low cost, which will allow us to tap
into the rapidly growing Canadian CBD market by supplying products that will be
priced much more competitively than current market offerings. This partnership
will also enable Zenabis to supply high-quality medical cannabis into Germany,
one of the largest medical cannabis markets in the world, thereby establishing
our position in the European cannabis market."
Farmako
founder and chief executive officer, Niklas Kouparanis, said, "Signing the
first deal in history to sell mass-produced CBD isolate created by biosynthesis
to Zenabis is a significant milestone for both Farmako and for the global
Cannabis industry. Being the first European company to enter into an agreement
to sell CBD isolates to the Canadian market puts Farmako at a significant
competitive advantage within the global market and also supports us in bridging
the gap between cannabis and pharmaceuticals. With our unique Continuous
Bacterial Cannabinoid Biosynthesis (CBCB) method using our patented Bacterium
Zynmomonas Cannabinoides®, we are able to produce nature-identical cannabinoids
very effectively and at very low costs on a large scale."
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement
to buy products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also
available on iTunes, Spotify, Google
Play Music, Stitcher, Spreaker, YouTube
via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use
of cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment